Today, fewer than 1 in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isnt serious enough for treatment, said David A Ricks, chair and CEO of Eli Lilly, in a statement
While their primary function targets blood sugar control and appetite regulation, these medications also influence: One of the most interesting aspects of GLP-1 medications is their relationship with the vagus nerve
Where combinations affect planning is in overall budget and protocol length decisions
The most common side effects involved gastrointestinal issues such as nausea, constipation and diarrhea
Its part of a class of drugs called glucagon-like peptide 1 (GLP-1) receptor agonists, which help people with Type 2 diabetes lower their blood sugar and reduce their risk for cardiovascular disease